Medpace shares surge in premarket on upbeat 2025 outlook, while Replimune tumbles on regulatory setback. Here's a look at some of today's top premarket movers.
In the Green
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com